FACTOR-II, FACTOR-VII, FACTOR-IX AND FACTOR-X CONCENTRATIONS IN PATIENTS RECEIVING LONG-TERM WARFARIN

被引:38
作者
PAUL, B
OXLEY, A
BRIGHAM, K
COX, T
HAMILTON, PJ
机构
[1] ROYAL VICTORIA INFIRM, DEPT HAEMATOL, NEWCASTLE UPON TYNE NE1 4LP, TYNE & WEAR, ENGLAND
[2] UNIV NEWCASTLE UPON TYNE, DEPT STAT, NEWCASTLE UPON TYNE NE1 7RU, TYNE & WEAR, ENGLAND
关键词
D O I
10.1136/jcp.40.1.94
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Using standard one stage clotting assays the concentrations of factors II, VII, IX and X were determined in 37 patients stabilised on warfarin for between three months and 17 years. Contrary to popular belief, the concentrations were not equally depressed, with factor X the lowest, factor II at intermediate value, factors VII and IX the highest. Some 71% of the variance of the British corrected ratio (BCR) could be accounted for by measurement of the factors assayed. Analysis of this variance showed 91% of the explained variance attributable to factor II, 7% to factor VII, 1.6% to factor IX and 0.4% to factor X. With the sudden and recent withdrawal of human thromboplastin, investigation of the sensitivities of the animal thromboplastins to changes in vitamin K dependent factors in orally anticoagulated patients is needed to ensure that the potentially alarming falls in factors II and X in these patients are being adequately detected.
引用
收藏
页码:94 / 98
页数:5
相关论文
共 15 条
[1]  
AUSTEN DEG, 1984, HUMAN BLOOD COAGULAT, P170
[2]  
BARROWCLIFFE TW, 1982, METHODS HAEMATOLOGY, V4, P41
[3]  
CONKIE JA, 1984, HAEMOSTASIS, V14, P307
[4]  
DUXBURY BM, 1985, HOSPITAL UPDATE, V11, P85
[5]  
GIDDINGS JC, 1980, INVESTIGATION HEREDI
[6]   EFFECT OF ORAL ANTICOAGULANTS ON FACTORS 7, 9, 10, AND 2 [J].
KAZMIER, FJ ;
SPITTELL, JA ;
THOMPSON, JJ ;
OWEN, CA .
ARCHIVES OF INTERNAL MEDICINE, 1965, 115 (06) :667-&
[7]   AN EVALUATION OF CHROMOGENIC SUBSTRATES IN THE CONTROL OF ORAL ANTI-COAGULANT THERAPY [J].
LATALLO, ZS ;
THOMSON, JM ;
POLLER, L .
BRITISH JOURNAL OF HAEMATOLOGY, 1981, 47 (02) :307-318
[8]   BEHAVIOUR OF FACTORS 2,7,9 + X IN BLEEDING COMPLICATIONS DURING LONG-TERM TREATMENT WITH COUMARIN [J].
LOELIGER, EA ;
MATTERN, MJ ;
HEMKER, HC ;
HENSEN, A .
THROMBOSIS ET DIATHESIS HAEMORRHAGICA, 1964, 10 (3-4) :278-&
[9]   BEHAVIOUR OF FACTORS II, VII, IX, AN X DURING LONG-TERM TREATMENT WITH COUMARIN [J].
LOELIGER, EA ;
MATTERN, MJ ;
BRABANDER, AS ;
VANDERESCH, B .
THROMBOSIS ET DIATHESIS HAEMORRHAGICA, 1963, 9 (1-2) :74-&
[10]  
LOELIGER EA, 1969, BOERHAAVE SERIES, P283